In the News

Julia Katz, MD, a pediatrics resident at St. Louis Children’s Hospital, worked with collaborators at Lurie Children’s Hospital in Chicago, to characterize precocious puberty in children with NF1 optic gliomas. Dr. Katz found that prior chemotherapy does not prevent the development of precocious puberty. Current work is now focused on better understanding the relationship between […]

David H. Gutmann, MD, PhD, the Donald O. Schnuck Family Professor and Director of the Washington University NF Center was awarded a fellowship to visit Heidelberg University. The purpose of the fellowship was to strengthen collaboration between researchers at both institutions in the areas of brain cancer.

The Wash U NF team happily hosted Springworks Therapeutics for a Day of NF Education in October 2024.  The Wash U team shared their multidisciplinary insights into the management of all aspects of NF1 care with the Springworks team. The day included a series of lectures from the providers, an educational mock tumor board as […]

 On Friday, November 9, Megan Ouyang presented her research at the Washington University Fall 2024 Undergraduate Research Symposium. Megan has been working with Dr. Jit Chatterjee on the role of the gut microbiota in controlling low-grade optic glioma growth in NF1. During the symposium, Megan discussed her findings and future research directions.

As the Washington University Neurofibromatosis (NF) Center enters its third decade of facilitating collaborations between clinicians and scientists, we celebrate the accomplishments of our members and the progress made towards personalizing our medical management of individuals living with NF. Over the past year, we have witnessed continued expansion of both our clinical and research programs, […]